Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Innovent Biologics Inc.

    OTC: IVBXF · Real-Time Price · USD
    12.73
    0.03 (0.24%)
    At close: Aug 22, 2025, 12:53 PM

    Innovent Biologics Cash Flow Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 297.99M -392.62M -888.76M -139.15M -1.23B -950.47M -1.73B -1B
    Depreciation & Amortization
    		 n/a 198.67M 183.14M 187.62M 151.85M 124.93M 112.66M 89.51M
    Stock-Based Compensation
    		 258.8M 297.72M 347.21M 226.99M 208.31M 261.18M 262.54M 239.04M
    Other Working Capital
    		 n/a -25.21M 575.82M -9.05M -402.53M 89.08M 769.8M 94.67M
    Other Non-Cash Items
    		 -556.79M -200.28M 301.1M -565.43M -490.97M 30.87M -215.95M 487.96M
    Deferred Income Tax
    		 n/a n/a n/a 96.89M -858.34M 101.11M n/a 822.5M
    Change in Working Capital
    		 n/a -119.13M 828.01M -332.93M 247.5M -273.21M 556.54M -828.39M
    Operating Cash Flow
    		 n/a -215.63M 770.7M -622.89M -1.11B -806.7M -1.01B -1.02B
    Capital Expenditures
    		 n/a -699.51M -521.48M -597.9M -467.9M -428.99M -717.31M -348.32M
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a 145.82M -1.2B 1.32B -1.35B 808.4M -1.76B 131.3M
    Investing Cash Flow
    		 n/a -553.69M -1.72B 725.04M -1.81B 379.41M -2.48B -217.02M
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a -260.81M 2.34B 244.69M 2.67B 223.72M 499.71M 4.5B
    Financial Cash Flow
    		 n/a -260.81M 2.34B 244.69M 2.67B 223.72M 499.71M 4.5B
    Net Cash Flow
    		 -1.71B -515.87M 706.71M 158.05M -167.94M -3.68M -1.55B 1.01B
    Free Cash Flow
    		 n/a -915.15M 249.22M -1.22B -1.58B -1.24B -1.73B -1.36B

    Add to Watchlist